Shenzhen Glory Medical Co.,Ltd. (SHE:002551)
China · Delayed Price · Currency is CNY 3.110
-0.090 (-2.81%)
Jun 2, 2026, 3:04 PM CST
Shenzhen Glory Medical Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Net Income | -155.35 | -139.58 | 22.28 | -148.89 | -308.06 | 44.52 |
Depreciation & Amortization | 100.82 | 100.82 | 102.39 | 95.88 | 125 | 76.68 |
Other Amortization | 0.86 | 0.86 | 2.5 | 3.51 | 3.26 | 6.57 |
Loss (Gain) From Sale of Assets | -10.1 | -10.1 | -0.12 | 0.03 | - | 0.03 |
Asset Writedown & Restructuring Costs | 11.95 | 11.95 | 3.2 | 13.94 | 73.06 | 1.23 |
Loss (Gain) From Sale of Investments | -13.21 | -13.21 | -4.02 | 3.37 | 102.94 | -28.53 |
Provision & Write-off of Bad Debts | 83.48 | 83.48 | 28.6 | 53.09 | 127.28 | 6.26 |
Other Operating Activities | -113.94 | -6.1 | 3.59 | 29.13 | 63.34 | 63.13 |
Change in Accounts Receivable | 74 | 74 | -144.58 | 29.17 | 156.27 | 49.62 |
Change in Inventory | 49.49 | 49.49 | 105.77 | 8.73 | -55.92 | -23.82 |
Change in Accounts Payable | 1.64 | 1.64 | 2.9 | -103.46 | -146.37 | 48.14 |
Operating Cash Flow | 16.66 | 140.27 | 120.95 | 17.63 | 96.45 | 242.6 |
Operating Cash Flow Growth | -89.82% | 15.97% | 585.90% | -81.72% | -60.24% | -51.24% |
Capital Expenditures | -131.32 | -125.26 | -82.15 | -42.07 | -57.3 | -429.97 |
Sale of Property, Plant & Equipment | 40.96 | 30.69 | 2.26 | 0.19 | 11.72 | 0.39 |
Divestitures | - | - | - | 1.08 | 1.5 | - |
Investment in Securities | -548.17 | 77.77 | -10.94 | 114.67 | -132.77 | -141.79 |
Other Investing Activities | -2.39 | - | 3.85 | - | - | 7.99 |
Investing Cash Flow | -640.92 | -16.81 | -86.98 | 73.87 | -176.85 | -563.39 |
Long-Term Debt Issued | - | 20 | - | - | 27.84 | 148.9 |
Long-Term Debt Repaid | - | -260.57 | -21.06 | -41.46 | -88.82 | -248.39 |
Net Debt Issued (Repaid) | -23.8 | -240.57 | -21.06 | -41.46 | -60.98 | -99.49 |
Issuance of Common Stock | - | - | - | - | - | 108.83 |
Common Dividends Paid | -22.72 | -22.36 | -11.03 | -58.85 | -163.95 | -30.29 |
Other Financing Activities | 30.69 | -29.1 | 27.73 | 21.7 | 33.84 | 29.27 |
Financing Cash Flow | -15.84 | -292.03 | -4.36 | -78.61 | -191.09 | 8.32 |
Foreign Exchange Rate Adjustments | -12.05 | 11.95 | 17.14 | 7.15 | 6.05 | 4.73 |
Net Cash Flow | -652.15 | -156.62 | 46.74 | 20.04 | -265.44 | -307.74 |
Free Cash Flow | -114.66 | 15 | 38.8 | -24.44 | 39.15 | -187.38 |
Free Cash Flow Growth | - | -61.33% | - | - | - | - |
Free Cash Flow Margin | -10.87% | 1.39% | 2.68% | -2.05% | 3.07% | -10.47% |
Free Cash Flow Per Share | -0.14 | 0.02 | 0.04 | -0.03 | 0.05 | -0.21 |
Cash Income Tax Paid | 6.91 | 3.66 | -7 | -2.51 | -29.91 | -4.52 |
Levered Free Cash Flow | -125.34 | -69.6 | 22.97 | 58.06 | 3.61 | -109.44 |
Unlevered Free Cash Flow | -115.96 | -59.84 | 26.62 | 59.31 | 6.39 | -104.92 |
Change in Working Capital | 112.16 | 112.16 | -37.47 | -32.42 | -90.37 | 72.69 |